Epidermal Growth Factor Receptor Inhibition With Gefitinib Does Not Alter Lung Responses to Mechanical Ventilation in Fetal, Preterm Lambs

PLoS ONE - United States
doi 10.1371/journal.pone.0200713
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Autophagic Degradation of Epidermal Growth Factor Receptor in Gefitinib-Resistant Lung Cancer by Celastrol

International Journal of Oncology
Cancer ResearchOncology
2016English

Epidermal Growth Factor Receptor Is Not Altered in Content or Function in Response to Oligohydramnios in the Fetal Lung. 295

Pediatric Research
Child HealthPediatricsPerinatology
1997English

Effect of Epidermal Growth Factor on Lung Liquid Production and Catecholamine Blood Levels in Fetal Lambs

Pediatric Research
Child HealthPediatricsPerinatology
1984English

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non-Small-Cell Lung Cancer to Gefitinib

Yearbook of Pulmonary Disease
2006English

Combining Chemotherapy With Epidermal Growth Factor Receptor Inhibition in Advanced Non-Small Cell Lung Cancer

Therapeutic Advances in Medical Oncology
Oncology
2012English

Epidermal Growth Factor Receptor Inhibition Strategies in Oncology

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2004English

Epidermal Growth Factor Acts as a Corticotropin-Releasing Factor in Chronically Catheterized Fetal Lambs.

Journal of Clinical Investigation
Medicine
1987English

Epidermal Growth Factor Receptor Inhibition in Lung Cancer: The Evolving Role of Individualized Therapy

Cancer and Metastasis Reviews
Cancer ResearchOncology
2010English

Chemopreventive Effects of Gefitinib on Nonsmoking-Related Lung Tumorigenesis in Activating Epidermal Growth Factor Receptor Transgenic Mice

Cancer Research
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy